Sinopharm
1099.HK
#2288
Rank
€6.04 B
Marketcap
1,94 €
Share price
0.60%
Change (1 day)
-25.86%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

EPS for Sinopharm (1099.HK)

EPS in 2022: 0,36 €

According to Sinopharm's latest financial reports the company's current EPS (TTM) is 0,36 €. In 2022 the company made an earnings per share (EPS) of 0,36 € an increase over its 2021 EPS that were of 0,35 €.

EPS history for Sinopharm from 2006 to 2022

Annual EPS

Year EPS Change
20220,36 €1.3%
20210,35 €10.33%
20200,32 €17.26%
20190,27 €5.44%
20180,26 €-0.87%
20170,26 €19.44%
20160,22 €15.3%
20150,19 €17.06%
20140,16 €21.9%
20130,13 €11.82%
20120,12 €25.24%
20110,09476 €31.02%
20100,07233 €3.3%
20090,07002 €46.85%
20080,04768 €67.57%
20070,02845 €310.24%
20060,006936 €